Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Pediatric Rheumatology · Hypocomplementemic Urticarial Vasculitis Syndrome

What Are HUVS Symptoms in Children? Diagnostic Tests

At a Glance

In children, hypocomplementemic urticarial vasculitis (HUVS) often causes hives lasting more than 24 hours that burn or bruise. Diagnosis combines a skin biopsy, immune-system blood tests, and ongoing urine and kidney checks because other organs may be affected.

In this answer

3 sections

01

Clinical Presentation and Urgent Warning Signs

02

The Diagnostic Workup

03

Pediatric Care Considerations

Children can develop hypocomplementemic urticarial vasculitis (HUVS), though it is an uncommon condition. While ordinary hives come and go quickly, HUVS presents with wheals (hives) that persist longer than 24 hours. These lesions may itch, but burning or pain is more characteristic, and they often leave behind bruising or hyperpigmentation (dark marks) as they fade [1][2].

Some children have disease that is mostly limited to the skin, but pediatric HUVS can also involve extracutaneous (systemic) symptoms affecting the joints, kidneys, eyes, lungs, and abdomen [3][4][5]. Because childhood HUVS can overlap with other conditions like systemic lupus erythematosus (SLE) or medication reactions, the evaluation process is comprehensive and requires pediatric specialists, such as a rheumatologist and dermatologist.

Clinical Presentation and Urgent Warning Signs

Along with the skin rash, children may experience systemic symptoms:

  • Joints: Joint pain (arthralgia) or objective joint swelling (arthritis) is often reported [3][4].
  • Kidneys: Renal involvement is a significant concern. It can range from microscopic blood or protein in the urine, which is invisible to the naked eye, to glomerulonephritis (inflammation of the kidney’s filtering units) [6][7].
  • Lungs: In rare cases, systemic HUVS can cause severe lung issues, such as pulmonary hemorrhage (bleeding into the lungs) [3][5].
  • Eyes and Abdomen: Eye involvement can include episcleritis, scleritis (inflammation of the deeper wall of the eye), or uveitis [8][9]. Abdominal pain from gastrointestinal inflammation can also occur [4][10].

Urgent Care Warning: Seek emergency or same-day medical assessment if your child develops any of the following: coughing up blood, new or severe trouble breathing, blue or gray lips, severe chest or abdominal pain, markedly reduced or dark/bloody urine, sudden new swelling, painful red eyes, light sensitivity, or sudden vision changes.

The Diagnostic Workup

HUVS is often a diagnosis of exclusion, meaning doctors must rule out infections, medication reactions, and other autoimmune disorders. The diagnostic process combines several tools:

  • Skin Biopsy: Taking a small sample of a fresh skin lesion can show leukocytoclastic vasculitis under a microscope. This confirms small-vessel inflammation in that specific lesion, but it does not by itself establish a diagnosis of HUVS [1][2].
  • Complement and Autoimmune Testing: Blood tests check for low levels of complement proteins (such as C1q, C3, and C4), which help regulate the immune system. Doctors may also test for anti-C1q antibodies and markers like antinuclear antibodies (ANA) or anti-dsDNA to check for lupus [3][11][12]. No single result establishes the diagnosis, and results may need periodic reassessment.
  • Kidney Monitoring: Because kidney disease can emerge silently over time, specialists will monitor blood pressure, routine urinalysis, urine protein-to-creatinine ratio, and blood tests measuring kidney function (like serum creatinine or eGFR) [4][13][14]. If findings are persistently abnormal, a kidney biopsy may be considered to guide treatment.
  • Genetic Considerations: For children with very early-onset disease, severe or recurrent symptoms, lupus-like features, or a strong family history, doctors may consider selective genetic testing. This looks for inherited conditions like DNASE1L3 deficiency or complement defects, which can mimic HUVS [3][15][16]. Genetic counseling is usually recommended to help interpret the results.

Pediatric Care Considerations

Managing HUVS in a growing child requires careful attention to their development and medication safety.

  • Growth and Bone Health: Chronic inflammation and medications like corticosteroids can affect a child’s linear growth (height velocity) and bone density. Doctors will monitor growth charts, fracture history, and ensure adequate calcium and vitamin D [17][18]. Bone-density testing may be ordered based on the child’s specific steroid exposure and clinical risk.
  • Medication Safety: Corticosteroids should never be stopped suddenly without medical advice. Because long-term use has potential adverse effects, doctors may consider adding steroid-sparing immunosuppressive drugs to reduce the immune system’s activity [19][20]. Families must watch for signs of infection (like fever) and report them promptly when a child is on these medications.
  • Vaccinations: Non-live vaccines (like the injectable flu shot or COVID-19 vaccine) are generally safe, though they may work less well during immunosuppressive therapy [21][22]. Live vaccines (like the nasal-spray flu vaccine, MMR, or chickenpox) are often avoided during significant immunosuppression, but rules depend on the exact medication, dose, and timing [23][24]. Review every vaccine with your child’s treating team, but do not delay urgent treatment solely to complete vaccinations.

Common questions in this guide

What does the HUVS rash look and feel like in a child?
HUVS lesions usually last longer than 24 hours, unlike ordinary hives. They may itch, but burning or pain is more typical, and they can leave bruising or darkened skin as they fade.
Which tests help doctors diagnose HUVS in children?
Doctors may biopsy a fresh skin lesion to look for inflammation in small blood vessels. Blood tests can measure complement proteins such as C1q, C3, and C4 and check for anti-C1q antibodies, ANA, or anti-dsDNA; the evaluation also rules out infections, medication reactions, and lupus.
How do doctors check whether HUVS is affecting a child's kidneys?
Kidney monitoring may include blood pressure checks, routine urine testing, a urine protein-to-creatinine ratio, and blood tests such as creatinine or eGFR. If abnormalities persist, a kidney biopsy may be considered because kidney involvement can develop without obvious symptoms.
When should a child with possible HUVS receive emergency or same-day care?
Seek urgent assessment for coughing up blood, new or severe trouble breathing, blue or gray lips, severe chest or abdominal pain, markedly reduced or bloody urine, sudden swelling, painful red eyes, light sensitivity, or sudden vision changes.
Can HUVS affect parts of the body besides the skin?
Yes. Children may develop joint pain or swelling, kidney inflammation, eye inflammation, abdominal symptoms, or, rarely, serious lung problems such as bleeding into the lungs. These symptoms should be reported promptly to the child's healthcare team.
Why might a child with HUVS be offered genetic testing?
Genetic testing may be considered when symptoms begin very early, are severe or recurrent, resemble lupus, or occur with a strong family history of immune-system disease. Testing may look for inherited conditions such as DNASE1L3 deficiency or complement defects, and genetic counseling helps families understand the results.
How are growth, medications, and vaccines managed in a child with HUVS?
Corticosteroids and other immune-suppressing medicines may require monitoring for infection, slowed growth, and reduced bone density, and steroids should not be stopped suddenly without medical advice. Non-live vaccines are generally safer during immune-suppressing treatment, while live vaccines may need to be avoided depending on the medicine, dose, and timing.

Related questions

When Should a Skin Biopsy Be Done for Suspected HUVS? What Diagnostic Criteria Are Used for HUVS Diagnosis? Can HUVS Cause Abdominal Pain or Gastrointestinal Bleeding? Can HUVS Cause Chronic Kidney Disease or Kidney Failure? Can Skin-Limited HUV Affect Your Kidneys or Lungs Later?
Show more
Can HUVS Cause Permanent Lung Damage or Airway Obstruction? How Can I Safely Relieve Itching and Burning From HUVS? How Is HUVS Distinguished From Lupus? Key Tests and Signs Should Familial or Early-Onset HUVS Get DNASE1L3 Testing? Is Exercise Safe With HUVS, Lung, and Kidney Disease? Is HUVS Contagious or Inherited? What Families Should Know What Diet Is Safe for People With HUVS Kidney Disease? How Accurate Are C1q and Anti-C1q Tests for HUVS? Explained What Causes HUVS? What Triggers Vasculitis Flares? What Eye Problems Can HUVS Cause, and When Is It Urgent? What Is the Long-Term Course of HUVS for Patients? What Is the Mortality Risk and Long-Term Prognosis of HUVS? Why Are C1q, C3, and C4 Low in HUVS? Explained for Patients Why Do HUVS Skin Lesions Leave Bruises and Dark Marks?

Get notified when new evidence is published on Hypocomplementemic urticarial vasculitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (24)
  1. 1

    Urticarial vasculitis and urticarial autoinflammatory syndromes.

    Marzano AV, Tavecchio S, Venturini M, et al.

    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia 2015; (150(1)):41-50.

    PMID: 25586657
  2. 2

    Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi survey.

    Krause K, Bonnekoh H, Jelden-Thurm J, et al.

    Clinical and translational allergy 2023; (13(10)):e12305 doi:10.1002/clt2.12305.

    PMID: 37876033
  3. 3

    Childhood-onset hypocomplementaemic urticarial vasculitis in France: phenotypic and genotypic diversity in 10 children.

    Bianchi C, Melki I, Sisirak V, et al.

    Pediatric rheumatology online journal 2026; (24(1)).

    PMID: 41807955
  4. 4

    Renal manifestations in hypocomplementic urticarial vasculitis syndrome: Is it a distinct pathology?

    AlHermi B, Al Mosawi Z, Mohammed D

    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2017; (28(4)):929-933.

    PMID: 28748901
  5. 5

    Hypocomplementemic Urticarial Vasculitis Syndrome or Systemic Lupus Erythematosus in Evolution?

    Kesarwani V, Phachu D, Trivedi R

    Cureus 2022; (14(3)):e23429 doi:10.7759/cureus.23429.

    PMID: 35481300
  6. 6

    Treatment and long-term follow-up of pediatric patients with hypocomplementemic urticarial vasculitis syndrome (HUVS): a case-based review.

    Taş Ö, Aydın F, Özçakar ZB

    Clinical rheumatology 2025; (44(7)):3109-3118 doi:10.1007/s10067-025-07509-6.

    PMID: 40455313
  7. 7

    Biopsy-proven kidney involvement in hypocomplementemic urticarial vasculitis.

    Corthier A, Jachiet M, Bertin D, et al.

    BMC nephrology 2022; (23(1)):67 doi:10.1186/s12882-022-02689-8.

    PMID: 35172758
  8. 8

    Urticarial vasculitis in pediatric systemic lupus erythematosus.

    Al Kamzari A, Al Musalhi B, Al Abrawi S, et al.

    Pediatric dermatology 2020; (37(4)):651-655 doi:10.1111/pde.14184.

    PMID: 32372441
  9. 9

    Hypocomplementemic urticarial vasculitis syndrome presenting with bilateral scleritis.

    Berry EC, Wells J, Morey A, Anantharajah A

    BMJ case reports 2021; (14(5)) doi:10.1136/bcr-2020-240041.

    PMID: 33972296
  10. 10

    Hypocomplementemic urticarial vasculitis syndrome with gastrointestinal vasculitis and crescentic membranoproliferative glomerulonephritis without immune complex deposits.

    Ueki K, Tsuchimoto A, Matsukuma Y, et al.

    CEN case reports 2020; (9(1)):30-35 doi:10.1007/s13730-019-00421-4.

    PMID: 31586313
  11. 11

    [Hypocomplementemic urticarial vasculitis].

    Jachiet M, Flageul B, Bouaziz JD, et al.

    La Revue de medecine interne 2018; (39(2)):90-98 doi:10.1016/j.revmed.2017.03.005.

    PMID: 28457680
  12. 12

    Management of urticarial vasculitis: A worldwide physician perspective.

    Kolkhir P, Bonnekoh H, Kocatürk E, et al.

    The World Allergy Organization journal 2020; (13(3)):100107 doi:10.1016/j.waojou.2020.100107.

    PMID: 32180892
  13. 13

    Kidney Involvement in Hypocomplementemic Urticarial Vasculitis Syndrome-A Case-Based Review.

    Ion O, Obrișcă B, Ismail G, et al.

    Journal of clinical medicine 2020; (9(7)) doi:10.3390/jcm9072131.

    PMID: 32640739
  14. 14

    [Hypocomplementemic urticarial vasculitis syndrome: a rare but not always benign condition].

    Sjöwall C, Skattum L, Olsson M, et al.

    Lakartidningen 2019; (116()).

    PMID: 31794046
  15. 15

    Unraveling the Clinical Spectrum of DNASE1L3 Deficiency: Insights from Case Series and Systematic Literature Review.

    Ercan Emreol H, Unal D, Sag E, et al.

    Current rheumatology reports 2026; (28(1)).

    PMID: 42726335
  16. 16

    Case Report: Hypocomplementemic urticarial vasculitis syndrome in a pediatric patient with complement factor 1 deficiency.

    Lin S, Kafisheh D, Elder ME

    Frontiers in pediatrics 2024; (12()):1448094 doi:10.3389/fped.2024.1448094.

    PMID: 39376673
  17. 17

    Glucocorticoid-Induced Osteoporosis: Why Kids Are Different.

    Ward LM

    Frontiers in endocrinology 2020; (11()):576 doi:10.3389/fendo.2020.00576.

    PMID: 33391179
  18. 18

    Growth and puberty in children with juvenile idiopathic arthritis.

    d'Angelo DM, Di Donato G, Breda L, Chiarelli F

    Pediatric rheumatology online journal 2021; (19(1)):28 doi:10.1186/s12969-021-00521-5.

    PMID: 33712046
  19. 19

    Treatment of urticarial vasculitis: A systematic review.

    Kolkhir P, Grakhova M, Bonnekoh H, et al.

    The Journal of allergy and clinical immunology 2019; (143(2)):458-466 doi:10.1016/j.jaci.2018.09.007.

    PMID: 30268388
  20. 20

    Off-label use of biologics in urticarial vasculitis: a European retrospective cohort study.

    Maisonobe L, Korganow AS, Berti A, et al.

    Rheumatology (Oxford, England) 2025; (64(7)):4309-4315 doi:10.1093/rheumatology/keaf039.

    PMID: 39847537
  21. 21

    Pediatric rheumatic diseases and vaccinations: a promising alliance.

    Corsello G, Gilotta C, Alizzi CG, et al.

    Frontiers in pediatrics 2025; (13()):1672792 doi:10.3389/fped.2025.1672792.

    PMID: 41395313
  22. 22

    Vaccinations in paediatric rheumatology: an update on current developments.

    Groot N, Heijstek MW, Wulffraat NM

    Current rheumatology reports 2015; (17(7)):46 doi:10.1007/s11926-015-0519-y.

    PMID: 26025339
  23. 23

    2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases.

    Bass AR, Chakravarty E, Akl EA, et al.

    Arthritis care & research 2023; (75(3)):449-464 doi:10.1002/acr.25045.

    PMID: 36597813
  24. 24

    Live attenuated vaccines under immunosuppressive agents or biological agents: survey and clinical data from Japan.

    Kamei K, Miyairi I, Shoji K, et al.

    European journal of pediatrics 2021; (180(6)):1847-1854 doi:10.1007/s00431-021-03927-1.

    PMID: 33523302

This page is for informational purposes only and does not constitute medical advice for a child with suspected HUVS. A pediatric rheumatologist or dermatologist should interpret symptoms and test results and guide urgent care.